Debut

United States - San Diego, California

• 02/06/2023
• Series B
• $34,000,000

Debut is an unconventional innovation company, integrating breakthrough biotechnology and brand creation to build businesses that represent the next generation of sustainable wellness. With proprietary screening, testing and cell-free biomanufacturing technology, we unlock novel actives to power global personal care and health brands. Our mission is to set a new standard for big business through our dynamic intrapreneurial model and to create purposeful brands that push humanity forward.

Related People

Joshua BrittonFounder

United States - San Diego, California,

Debut Biotech harnesses nature, science and creativity to build big businesses that represent the next generation of sustainable beauty. Powered by breakthrough technology and human-centered brand innovation, we are reimagining the world of cosmetic active ingredients to help consumers live better.

We are the only biotech company with fully vertical integration capabilities incorporating ingredient discovery, biofermentation, formulation, finished clinically-backed scalable ingredients and brand creation, all delivered at unprecedented speed.

Everything that we do is aimed at creating the highest performing, safest and most sustainable novel ingredients, products and brands that will accelerate the transformation of the beauty industry as we know it.

LinkedIn https://www.linkedin.com/in/joshua-britton-4294a080/